BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahn SH, Han KH, Park JY, Lee CK, Kang SW, Chon CY, Kim YS, Park K, Kim DK, Moon YM. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology. 2000;31:1371-1373. [PMID: 10827165 DOI: 10.1053/jhep.2000.7988] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Triolo M, Della Corte C, Colombo M. Impact of HBV therapy on the incidence of hepatocellular carcinoma. Liver Int. 2014;34 Suppl 1:139-145. [PMID: 24373091 DOI: 10.1111/liv.12394] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
2 Doh H, Roh S, Lee KW, Kim K. Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes. FEMS Immunol Med Microbiol 2003;35:77-85. [PMID: 12589960 DOI: 10.1016/S0928-8244(02)00461-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
3 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
4 Romporn S, Hirankarn N, Tangkijvanich P, Kimkong I. Association of IFNAR2 and IL10RB genes in chronic hepatitis B virus infection. Tissue Antigens 2013;82:21-5. [PMID: 23745570 DOI: 10.1111/tan.12133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006; 12(30): 4788-4793 [PMID: 16937459 DOI: 10.3748/wjg.v12.i30.4788] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
6 Chen DQ, Zeng Y, Zhou J, Yang L, Jiang S, Huang JD, Lu L, Zheng BJ. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. J Med Virol. 2010;82:371-378. [PMID: 20087947 DOI: 10.1002/jmv.21716] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
7 Li X, Liu W, Wang H, Jin X, Fang S, Shi Y, Liu Z, Zhang S, Yang S. The influence of HLA alleles and HBV subgenotyes on the outcomes of HBV infections in Northeast China. Virus Res. 2012;163:328-333. [PMID: 22056847 DOI: 10.1016/j.virusres.2011.10.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
8 Cho SW, Cheong JY, Ju YS, Oh do H, Suh YJ, Lee KW. Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J Korean Med Sci. 2008;23:838-844. [PMID: 18955791 DOI: 10.3346/jkms.2008.23.5.838] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
9 Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012;12:320-325. [PMID: 22783343 DOI: 10.5812/hepatmon.6094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
10 Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat. 2007;14:841-848. [PMID: 18070287 DOI: 10.1111/j.1365-2893.2007.00880.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 48] [Article Influence: 0.6] [Reference Citation Analysis]
11 Song BC, Cui XJ, Kim H. Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection. Intervirology. 2005;48:133-137. [PMID: 15812186 DOI: 10.1159/000081740] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 3.4] [Reference Citation Analysis]
12 Wu Y, Wang L, Lee T, Lin HH, Hu C, Cheng M, Lo S. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 2004;72:17-25. [DOI: 10.1002/jmv.10557] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
13 Cao T, Meuleman P, Desombere I, Sällberg M, Leroux-Roels G. In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model. J Virol. 2001;75:11449-11456. [PMID: 11689626 DOI: 10.1128/JVI.75.23.11449-11456.2001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
14 Yoon JH, Shin S, In Jw, Chang JY, Song EY, Roh EY. Association of HLA alleles with the responsiveness to hepatitis B virus vaccination in Korean infants. Vaccine. 2014;32:5638-5644. [PMID: 25148772 DOI: 10.1016/j.vaccine.2014.08.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
15 Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology. 2012;55:1426-1431. [PMID: 22105689 DOI: 10.1002/hep.24799] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 12.3] [Reference Citation Analysis]
16 Corrêa BDM, de Almeida Lopes EP, Militão de Albuquerque MDFP, Dourado L. Association between HLA-DRB1* polymorphisms and hepatitis B infection in a Brazilian population. Revista da Associação Médica Brasileira 2012;58:537-42. [DOI: 10.1016/s0104-4230(12)70246-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13(12): 1770-1787 [PMID: 17465466 DOI: 10.3748/wjg.v13.i12.1770] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 135] [Article Influence: 9.2] [Reference Citation Analysis]
18 Tao J, Su K, Yu C, Liu X, Wu W, Xu W, Jiang B, Luo R, Yao J, Zhou J. Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection. Amino Acids. 2015;47:2623-2634. [PMID: 26197724 DOI: 10.1007/s00726-015-2054-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
19 Corrêa Bde M, Lopes EP, Albuquerque Mde F, Dourado L. Association between HLA-DRB1* polymorphisms and hepatitis B infection in a brazilian population. Rev Assoc Med Bras (1992) 2012;58:537-42. [PMID: 23090223 [PMID: 23090223 DOI: 10.1590/s0104-42302012000500009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Andrade Júnior DRD, Andrade DRD. The influence of the human genome on chronic viral hepatitis outcome. Rev Inst Med trop S Paulo 2004;46:119-26. [DOI: 10.1590/s0036-46652004000300001] [Cited by in Crossref: 27] [Article Influence: 1.5] [Reference Citation Analysis]
21 Abbott W, Gane E, Winship I, Munn S, Tukuitonga C. Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenetics 2007;59:187-95. [PMID: 17211638 DOI: 10.1007/s00251-006-0184-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
22 Lee SK, Yi CH, Kim MH, Cheong JY, Cho SW, Yang SJ, Kwack K. Genetic association between functional haplotype of collagen type III alpha 1 and chronic hepatitis B and cirrhosis in Koreans. Tissue Antigens 2008;72:539-48. [PMID: 19000145 DOI: 10.1111/j.1399-0039.2008.01144.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
23 Kapoor R, Kottilil S. Strategies to eliminate HBV infection. Future Virol 2014;9:565-85. [PMID: 25309617 DOI: 10.2217/fvl.14.36] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
24 Thursz M. Pros and cons of genetic association studies in hepatitis B. Hepatology. 2004;40:284-286. [PMID: 15368431 DOI: 10.1002/hep.20319] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
25 Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y. Interleukin-1β gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 2006; 12(5): 776-779 [PMID: 16521194 DOI: 10.3748/wjg.v12.i5.776] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
26 Yang G, Liu J, Han S, Xie H, Du R, Yan Y, Xu D, Fan D. Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens. 2007;69:170-175. [PMID: 17257320 DOI: 10.1111/j.1399-0039.2006.00744.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
27 Höhler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, Vollmar J, Schneider PM, Fimmers R. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet. 2002;360:991-995. [PMID: 12383669 DOI: 10.1016/s0140-6736(02)11083-x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
28 Cheong JY, Shin HD, Kim YJ, Cho SW. Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. J Med Virol 2013;85:808-14. [DOI: 10.1002/jmv.23551] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
29 Han K, Kim K, Chang HY. Immunogenetics of hepatitis B virus infection: Immunogenetics of HBV infection. Journal of Gastroenterology and Hepatology 2002;17:S329-32. [DOI: 10.1046/j.1440-1746.17.s3.22.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 2013;8:e66920. [PMID: 23825586 DOI: 10.1371/journal.pone.0066920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
31 Deng G, Zhou G, Zhai Y, Li S, Li X, Li Y, Zhang R, Yao Z, Shen Y, Qiang B. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology. 2004;40:318-326. [PMID: 15368436 DOI: 10.1002/hep.20318] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 3.8] [Reference Citation Analysis]
32 Jazayeri MS, Basuni AA, Cooksley G, Locarnini S, Carman WF. Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region. J Hepatol. 2004;41:139-146. [PMID: 15246220 DOI: 10.1016/j.jhep.2004.03.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
33 Wang T, Shen C, Chen L, Liu S, Ji Y. Association of human leukocyte antigen polymorphisms with occult hepatitis B virus infection in a Shaanxi Han population. J Gene Med 2017;19. [PMID: 28940887 DOI: 10.1002/jgm.2987] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
34 Wei KL, Chen WQ, Wu JZ, Wu JL, Ning QY, Li HY. Association between HLA-DRB1* 09/12/15 alleles and HBV-related hepatic diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(27): 2570-2575 [DOI: 10.11569/wcjd.v20.i27.2570] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Al-Qahtani AA, Al-Anazi MR, Abdo AA, Sanai FM, Al-Hamoudi W, Alswat KA, Al-Ashgar HI, Khalaf NZ, Eldali AM, Viswan NA. Association between HLA variations and chronic hepatitis B virus infection in Saudi Arabian patients. PLoS One. 2014;9:e80445. [PMID: 24465366 DOI: 10.1371/journal.pone.0080445] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
36 Niro GA, Fontana R, Gioffreda D, Valvano MR, Lacobellis A, Facciorusso D, Andriulli A. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int. 2005;25:1175-1181. [PMID: 16343069 DOI: 10.1111/j.1478-3231.2005.01166.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
37 Cao T, Desombere I, Vanlandschoot P, Sällberg M, Leroux-Roels G. Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B. J Gen Virol. 2002;83:3023-3033. [PMID: 12466479 DOI: 10.1099/0022-1317-83-12-3023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
38 Zhang X, Hong X, Deng G, Bai X. Single nucleotide polymorphisms and functional analysis of class II transactivator (CIITA) promoter IV in persistent HBV infection. J Clin Virol 2007;40:197-201. [PMID: 17919972 DOI: 10.1016/j.jcv.2007.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
39 Park MH, Song EY, Ahn C, Oh KH, Yang J, Kang SJ, Lee HS. Two subtypes of hepatitis B virus-associated glomerulonephritis are associated with different HLA-DR2 alleles in Koreans. Tissue Antigens. 2003;62:505-511. [PMID: 14617034 DOI: 10.1046/j.1399-0039.2003.00141.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
40 Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011;53:422-428. [PMID: 21274863 DOI: 10.1002/hep.24048] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 8.6] [Reference Citation Analysis]
41 Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, Aghakhani A, Gachkar L, Velayati AA. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol. 2008;23:1716-1721. [PMID: 18761557 DOI: 10.1111/j.1440-1746.2008.05482.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
42 Chatzidaki V, Kouroumalis E, Galanakis E. Hepatitis B virus acquisition and pathogenesis in childhood: host genetic determinants. J Pediatr Gastroenterol Nutr. 2011;52:3-8. [PMID: 21119536 DOI: 10.1097/mpg.0b013e3181fb0cb9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
43 Kim BH, Kim YJ, Jeong SH, Tak WY, Ahn SH, Lee YJ, Jung EU, Lee JI, Yeon JE, Hwang JS, Um SH, Seo YS, Kim YS, Song BC, Kim JH, Jung YK, Park CK, Kim KA, Min HJ, Cho EY, Lee ES, Kwon SY, Chae HB, Kim DJ, Shin SR. Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study. J Gastroenterol Hepatol. 2013;28:128-134. [PMID: 23033899 DOI: 10.1111/j.1440-1746.2012.07292.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
44 Wang L, Zou ZQ, Wang K. Clinical Relevance of HLA Gene Variants in HBV Infection. J Immunol Res. 2016;2016:9069375. [PMID: 27243039 DOI: 10.1155/2016/9069375] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
45 Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22:370-385, Table of Contents. [PMID: 19366919 DOI: 10.1128/CMR.00048-08] [Cited by in Crossref: 196] [Cited by in F6Publishing: 100] [Article Influence: 15.1] [Reference Citation Analysis]
46 Wang HY, Li D, Liu W, Jin X, Du B, Li YP, Gu HX, Zhang SY. Hepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast China. Clin Microbiol Infect. 2010;16:477-481. [PMID: 19456822 DOI: 10.1111/j.1469-0691.2009.02834.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
47 Cox NR, Patel K, Tillmann HL. A Rationalized Approach to the Treatment of Patients Infected with Hepatitis B. Mol Diagn Ther 2014;18:203-12. [DOI: 10.1007/s40291-013-0072-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Bronowicki JP, Abdelmouttaleb I, Peyrin-Biroulet L, Venard V, Khiri H, Chabi N, Amouzou EK, Barraud H, Halfon P, Sanni A. Methylenetetrahydrofolate reductase 677 T allele protects against persistent HBV infection in West Africa. J Hepatol. 2008;48:532-539. [PMID: 18222012 DOI: 10.1016/j.jhep.2007.11.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
49 Han YN, Yang JL, Zheng SG, Tang Q, Zhu W. Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patients. World J Gastroenterol 2005; 11(36): 5721-5724 [PMID: 16237774 DOI: 10.3748/wjg.v11.i36.5721] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
50 Cho S, Chang SE, Kim KR, Choi JH, Sung KJ, Moon KC, Koh JK. Waldenström's macroglobulinaemia presenting as reticulate purpura and bullae in a patient with hepatitis B virus infection. Clin Exp Dermatol 2001;26:513-7. [PMID: 11678879 DOI: 10.1046/j.1365-2230.2001.00880.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
51 Wu JF, Chen CH, Hsieh RP, Shih HH, Chen YH, Li CR, Chiang CY, Shau WY, Ni YH, Chen HL. HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: a long-term prospective sibling cohort study in Taiwan. J Pediatr. 2006;148:647-651. [PMID: 16737879 DOI: 10.1016/j.jpeds.2005.12.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhi-ming L, Yu-lian J, Zhao-lei F, Chun-xiao W, Zhen-fang D, Bing-chang Z, Yue-ran Z. Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. Croat Med J 2007;48:800-6. [PMID: 18074414 DOI: 10.3325/cmj.2007.6.800] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
53 Wang C, Zhang X, Zhu B, Hu D, Wu J, Yu R, Zhao W. Relationships between tumour necrosis factor-α, interleukin-12B and interleukin-10 gene polymorphisms and hepatitis B in Chinese Han haemodialysis patients. Nephrology (Carlton) 2012;17:167-74. [PMID: 22070668 DOI: 10.1111/j.1440-1797.2011.01539.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
54 Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006;21:1163-1169. [PMID: 16824070 DOI: 10.1111/j.1440-1746.2006.04304.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 5.6] [Reference Citation Analysis]
55 Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts. J Biomed Sci. 2015;22:92. [PMID: 26487087 DOI: 10.1186/s12929-015-0199-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
56 Jazayeri SM, Basuni AA, Sran N, Gish R, Cooksley G, Locarnini S, Carman WF. HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. J Viral Hepat. 2004;11:488-501. [PMID: 15500549 DOI: 10.1111/j.1365-2893.2004.00534.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
57 Ryu HJ, Kim DY, Park JY, Chang HY, Lee MH, Han K, Chon CY, Ahn SH. Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2. J Med Virol 2011;83:2088-95. [DOI: 10.1002/jmv.22238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
58 Ren L, Deng Y, Wang HJ, Ren B, Niu XY, Fan HN. Association of the HLA-DRB1 gene with clinical outcome of Tibetan patients with hepatitis B in Qinghai. Shijie Huaren Xiaohua Zazhi 2011; 19(18): 1899-1903 [DOI: 10.11569/wcjd.v19.i18.1899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Uhmn S, Kim D, Ko Y, Cho S, Cheong J, Kim J. A study on application of single nucleotide polymorphism and machine learning techniques to diagnosis of chronic hepatitis. Expert Systems 2009;26:60-9. [DOI: 10.1111/j.1468-0394.2008.00491.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Chong WP, To YF, Ip WK, Yuen MF, Poon TP, Wong WH, Lai CL, Lau YL. Mannose-binding lectin in chronic hepatitis B virus infection. Hepatology. 2005;42:1037-1045. [PMID: 16231358 DOI: 10.1002/hep.20891] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
61 Tayebi S, Mohamadkhani A. The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection. Hepat Res Treat 2012;2012:493219. [PMID: 23133749 DOI: 10.1155/2012/493219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
62 Xu YY, Yu JY, Zhong YW, Song HB, Liu HH, Jia LL, Li SL, Xu JQ, Li Q. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus. Int J Biol Sci 2008;4:111-5. [PMID: 18463715 DOI: 10.7150/ijbs.4.111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
63 Albayrak A, Ertek M, Tasyaran MA, Pirim I. Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey. Biochem Genet. 2011;49:258-269. [PMID: 21188498 DOI: 10.1007/s10528-010-9404-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
64 Tong HV, Thomas Bock C, Velavan TP. Genetic insights on host and hepatitis B virus in liver diseases. Mutation Research/Reviews in Mutation Research 2014;762:65-75. [DOI: 10.1016/j.mrrev.2014.06.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
65 Hadziyannis SJ, Vassilopoulos D. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res. 2001;52:91-98. [PMID: 11672818 DOI: 10.1016/S0166-3542(01)00173-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
66 Katrinli S, Enc FY, Ozdil K, Ozturk O, Tuncer I, Doganay GD, Doganay L. Effect of HLA-DPA1 alleles on chronic hepatitis B prognosis and treatment response. North Clin Istanb. 2017;3:168-174. [PMID: 28275747 DOI: 10.14744/nci.2016.27870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
67 Ahn SH, Yuen L, Han KH, Littlejohn M, Chang HY, Damerow H, Ayres A, Heo J, Locarnini S, Revill PA. Molecular and clinical characteristics of hepatitis B virus in Korea. J Med Virol. 2010;82:1126-1134. [PMID: 20513074 DOI: 10.1002/jmv.21844] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
68 Lee JM, Ahn SH. Quantification of HBsAg: Basic virology for clinical practice. World J Gastroenterol 2011; 17(3): 283-289 [PMID: 21253386 DOI: 10.3748/wjg.v17.i3.283] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
69 Torres-Cornejo A, Lauer GM. Hurdles to the Development of Effective HBV Immunotherapies and HCV Vaccines. Pathog Immun 2017;2:102-25. [PMID: 28664194 DOI: 10.20411/pai.v2i1.201] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
70 Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells. Front Immunol 2017;8:197. [PMID: 28289418 DOI: 10.3389/fimmu.2017.00197] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
71 Carrozzo M, Brancatello F, Dametto E, Arduino P, Pentenero M, Rendine S, Porter SR, Lodi G, Scully C, Gandolfo S. Hepatitis C virus-associated oral lichen planus: is the geographical heterogeneity related to HLA-DR6. J Oral Pathol Med. 2005;34:204-208. [PMID: 15752254 DOI: 10.1111/j.1600-0714.2005.00303.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
72 Yoon YJ, Chang HY, Ahn SH, Kim JK, Park YK, Kang DR, Park JY, Myoung SM, Kim DY, Chon CY, Han K. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Carcinogenesis 2008;29:1192-6. [DOI: 10.1093/carcin/bgn090] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
73 Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One. 2011;6:e24221. [PMID: 21904616 DOI: 10.1371/journal.pone.0024221] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
74 Jiang X, Ma Y, Cui W, Li MD. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes. Amino Acids 2014;46:1819-26. [DOI: 10.1007/s00726-014-1767-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
75 Cheong JY, Cho SW, Choi JY, Lee JA, Kim MH, Lee JE, Hahm KB, Kim JH. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J Korean Med Sci. 2007;22:529-535. [PMID: 17596666 DOI: 10.3346/jkms.2007.22.3.529] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
76 Cheong JY, Cho SW, Lee JA, Lee KJ, Wang HJ, Lee JE, Kim JH. Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection. J Korean Med Sci. 2008;23:61-65. [PMID: 18303200 DOI: 10.3346/jkms.2008.23.1.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Ahn SH, Kim do Y, Chang HY, Hong SP, Shin JS, Kim YS, Kim H, Kim JK, Paik YH, Lee KS. Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol. 2006;78:1564-1571. [PMID: 17063508 DOI: 10.1002/jmv.20739] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
78 Talaat RM, Dondeti MF, El-Shenawy SZ, Khamiss OA. Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population. Biochem Genet 2014;52:387-402. [PMID: 24838671 DOI: 10.1007/s10528-014-9655-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
79 Zhang XL, Ni XC, Jia JH, Dong JH, Yu FX, Ma N, Liu XH, Li M, Liu DW. Association of the rs3077 and rs9277535 polymorphisms in HLA-DP with hepatitis B virus infection and spontaneous clearance: a meta-analysis. Scand J Gastroenterol. 2013;48:736-744. [PMID: 23601003 DOI: 10.3109/00365521.2013.787643] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
80 Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
81 Murali V, Rathika C, Ramgopal S, Padma Malini R, Arun Kumar MJ, Neethi Arasu V, Jeyaram Illiayaraja K, Balakrishnan K. Susceptible and protective associations of HLA DRB1*/DQB1* alleles and haplotypes with ischaemic stroke. Int J Immunogenet 2016;43:159-65. [PMID: 27105925 DOI: 10.1111/iji.12266] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
82 Cheng WH, He HT, Zhang MX, Liu ZH, Zhou YX. Expression of HLA-I on HepG2 cells by hepatitis B virus nucleocapsid mutants. Shijie Huaren Xiaohua Zazhi 2003; 11(7): 966-969 [DOI: 10.11569/wcjd.v11.i7.966] [Reference Citation Analysis]
83 Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
84 Park YK, Lee JM, Kim DY, Chang HY, Kim JK, Lee CK, Park JY, Ahn SH, Lee KS, Han KH. Association Between Polymorphism of Tumor Necrosis Factor-α Promoter and Response to Lamivudine Treatment in Patients with Chronic Hepatitis B. Dig Dis Sci 2010;55:2043-8. [DOI: 10.1007/s10620-009-0983-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
85 Zhang XQ, Hong XJ, Bai XJ. Susceptibility to active decompensated cirrhosis is associated with polymorphisms of intercellular adhesion molecule-1 (ICAM-1) in chronic HBV carriers. J Viral Hepat 2008;15:173-8. [PMID: 18233990 DOI: 10.1111/j.1365-2893.2007.00931.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
86 Li J, Han Y, Jin K, Wan Y, Wang S, Liu B, Liu Y, Lu S, Huang Z. Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection. Virol J. 2011;8:199. [PMID: 21535873 DOI: 10.1186/1743-422x-8-199] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
87 Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9(4): 641-644 [PMID: 12679901 DOI: 10.3748/wjg.v9.i4.641] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 81] [Article Influence: 4.5] [Reference Citation Analysis]
88 Futagawa Y, Waki K, Cai J. The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis caucasian patients receiving a liver transplant. Liver Transpl 2006;12:600-4. [DOI: 10.1002/lt.20678] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
89 Constantinescu I, Boșcaiu V, Cianga P, Dinu AA, Gai E, Melinte M, Moise A. The frequency of HLA alleles in the Romanian population. Immunogenetics 2016;68:167-78. [PMID: 26711124 DOI: 10.1007/s00251-015-0891-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
90 Kim BK, Han K, Ahn SH. Hepatitis B Virus Serology to Predict Antiviral Response in Chronic Hepatitis B. Digestion 2011;84:29-34. [DOI: 10.1159/000334076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
91 Kim BK, Han K, Ahn SH. Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection. Oncology 2011;81:41-9. [DOI: 10.1159/000333258] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
92 Hennig BJ, Hall AJ. Host genetic factors in hepatitis B infection, liver cancer and vaccination response: a review with a focus on Africa. Sci Total Environ 2012;423:202-9. [PMID: 20970823 DOI: 10.1016/j.scitotenv.2010.09.036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
93 Lin HH, Liao HW, Lin SK, Wang LY. HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine. 2008;26:3414-3420. [PMID: 18501999 DOI: 10.1016/j.vaccine.2008.04.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
94 Gupta S, Altice FL. Hepatitis B virus infection in US correctional facilities: a review of diagnosis, management, and public health implications. J Urban Health 2009;86:263-79. [PMID: 19184447 DOI: 10.1007/s11524-008-9338-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]